Cheryl Cohen, Director at ImmunityBio, Inc. (IBRX), sold 88,929 shares at $10.12 ($900K) on 2021-08-17, disclosed to the SEC on 2021-08-19.
Open-market sale of $900k IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.12 | 43,398 | $439K | 48.8% |
| 2 | $10.12 | 43,398 | $439K | 48.8% |
| 3 | $10.03 | 2,133 | $21K | 2.4% |
| Total | $10.12 avg | 88,929 | $900K | 100% |
| Filing → |
| IBRX | SELL | 2021-08-24 | $399K | — | Filing → |
| NK | SELL | 2020-08-13 | $299K | — | Filing → |
| VTL | SELL | 2018-09-14 | $2K | — | Filing → |